M-SOLIFENACIN SUCCINATE

mantra pharma inc🇨🇦 Health Canada

Approval Id: 510638530afa6048
Drug Approval Canada Name: M-SOLIFENACIN SUCCINATE
Product Name: M-SOLIFENACIN SUCCINATE
Status: Marketed
Status Date: 2023-08-18
Original Market Date: 2023-08-18
Din: 02529696
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 86:12.04
Atc Original: G04BD08 SOLIFENACIN
Atc Name: g 04 bd 08
Aig Number: 0151584001
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

SOLIFENACIN SUCCINATE

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

510638530afa6048

Type

Standard